QNRX Quoin Pharmaceuticals Ltd.
Nasdaq · SEC CIK 1671502 · EDGAR
- Bought, last 12 months
- $408.6K 5 purchases by 5 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 52 since 2023-10-30, latest 2026-09-01 21:40
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| LANGER DENNIS | Dir | $128.6K | — |
| Myers Michael | CEO, Dir | $100.0K | — |
| Carter Denise P. | COO, Dir | $100.0K | — |
| Lawlor Sally Bridget | CFO | $50.0K | — |
| Culverwell Anthony James | Dir | $30.0K | — |
Transactions 15
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-01 21:40 | 2026-08-31 | QNRX | Carter Denise P. | COO, Dir | P - Purchase | $4.88 | +20.5K | 37.7K | +119% | +$100.0K |
| D | 2026-09-01 21:39 | 2026-08-31 | QNRX | Myers Michael | CEO, Dir | P - Purchase | $4.88 | +20.5K | 37.7K | +119% | +$100.0K |
| D | 2026-09-01 21:39 | 2026-08-31 | QNRX | Lawlor Sally Bridget | CFO | P - Purchase | $4.88 | +10.2K | 10.7K | +2,328% | +$50.0K |
| D | 2026-09-01 21:38 | 2026-08-31 | QNRX | Culverwell Anthony James | Dir | P - Purchase | $4.88 | +6,146 | 40.4K | +18% | +$30.0K |
| 2026-08-28 18:40 | 2026-08-27 | QNRX | LANGER DENNIS | Dir | A - Grant | $5.15 | +34.5K | 56.2K | +159% | +$177.9K | |
| 2026-08-28 18:39 | 2026-08-27 | QNRX | Culverwell Anthony James | Dir | A - Grant | $5.15 | +31.4K | 34.2K | +1,094% | +$161.5K | |
| D | 2025-10-15 | 2025-10-14 | QNRX | LANGER DENNIS | Dir | P - Purchase | $8.49 | +15.2K | 15.2K | +1,515,200% | +$128.6K |
| D | 2024-12-27 | 2024-12-23 | QNRX | Myers Michael | CEO, Dir | P - Purchase | $0.45 | +555.6K | 602.8K | +1,176% | +$250.0K |
| D | 2024-12-27 | 2024-12-23 | QNRX | Carter Denise P. | COO, Dir | P - Purchase | $0.45 | +555.6K | 602.6K | +1,180% | +$250.0K |
| D | 2024-12-27 | 2024-12-23 | QNRX | Dunn Gordon | CFO | P - Purchase | $0.45 | +122.2K | 151.1K | +424% | +$55.0K |
| D | 2024-12-27 | 2024-12-23 | QNRX | Culverwell Anthony James | Dir | P - Purchase | $0.45 | +100.0K | 100.3K | +31,546% | +$45.0K |
| M | 2024-09-11 | 2024-09-09+ | QNRX | Dunn Gordon | CFO | P - Purchase | $0.8042 | +28.9K | 28.9K | New | +$23.2K |
| M | 2024-09-05 | 2024-09-03+ | QNRX | Carter Denise P. | COO, Dir | P - Purchase | $0.7649 | +37.7K | 47.1K | +403% | +$28.9K |
| M | 2024-09-05 | 2024-09-03+ | QNRX | Myers Michael | CEO, Dir | P - Purchase | $0.7657 | +37.9K | 23.7K | New | +$29.0K |
| 2024-06-10 | 2024-06-07 | QNRX | LANGER DENNIS | Dir | S - Sale | $0.73 | -297 | 53 | -85% | -$216.81 |
Purchase Sale Sale after option exercise All abbreviations